Publication | Open Access

Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers

Preoperative ChemotherapyBreast OncologyMedicinePharmacologyGynecologyWeekly PaclitaxelBreast CancerCancer TreatmentOncologyTumor BiologyEndocrine-related Cancer